The North America allergy immunotherapies market was valued at US$ 697.53 million in 2019 and is projected to reach US$ 1,634.17 million by 2027; it is expected to grow at a CAGR of 11.3% during the forecast period.
This can be attributed to the growing developments in the healthcare sector due to R and D activities in this industry. The increasing initiatives taken by various research institutes and organizations for improving medical facilities and services are further leading to North America Allergy Immunotherapies market growth.Allergen immunotherapy is a medical treatment useful for environmental allergies, allergies to insect bites, and asthma. According to the American Academy of Allergy, Asthma, and Immunology (AAAAI), nearly 7.8% of people aged 18 years and above in the U.S. have allergy rhinitis. Worldwide, around 30% of the total population is affected by hay fever annually. Thus, growing infection rates and the adoption of advanced treatment methods will favorably impact allergy immunotherapy market revenue share over the upcoming years. Positive clinical results of various immunotherapies, which are undergoing clinical trials, support the development of allergy immunotherapy-based drugs. Firms are adopting business expansion strategies and collaborations and new product development to increase their market footprint. This strategy will help the company in strengthening its market position by geographical expansion.
The Covid-19 pandemic has harmed allergy immunotherapies market size, with small and medium scale companies struggling to sustain their businesses in the near-term future. Industry leaders are now focusing on creating new business practices to deal with crises like covid-19 pandemic.
North America Allergy Immunotherapies Market Revenue and Forecast to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
NORTH AMERICA ALLERGY IMMUNOTHERAPIES MARKET SEGMENTATION
North America Allergy Immunotherapies Market – By Treatment
- Subcutaneous Immunotherapy (SCIT)
- Sublingual Immunotherapy (SLIT)
North America Allergy Immunotherapies Market – By Allergy Type
- Allergic Rhinitis
- Asthma
- Food Allergy
- Venom Allergy
- Others
North America Allergy Immunotherapies Market – By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
North America Allergy Immunotherapies Market – By Country
- United States
- Canada
- Mexico
Company Profiles
- Johnson and Johnson Services, Inc.
- ALK Abello A/S
Aimmune Therapeutics
- Anergis
Circassia
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Treatment and Sublingual Immunotherapy , Allergy type, Distribution Channel and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Allergy Immunotherapies Market – By Treatment
1.3.2 North America Allergy Immunotherapies Market – By Allergy Type
1.3.3 North America Allergy Immunotherapies Market – By Distribution Channel
1.3.4 North America Allergy Immunotherapies Market – By Geography
2. North America Allergy Immunotherapies Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Allergy Immunotherapies Market – Market Landscape
4.1 Overview
4.2 North America - PEST Analysis
4.3 Expert Opinion
5. North America Allergy immunotherapies Market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Prevalence of Allergic Disorders
5.1.2 Technological Advancements in Sublingual Dosage Formulations
5.2 Key Market Restraint
5.2.1 Drawbacks Associated with the Use of Allergy Immunotherapy
5.2.2 Regulatory Variations Across Regions
5.3 Key Market Opportunities
5.3.1 Presence of Strong Product Pipeline
5.4 Future Trends
5.4.1 Increasing FDA Approvals for Drugs
5.5 Impact Analysis
6. Allergy Immunotherapies Market – North America Analysis
6.1.1 North America: Allergy immunotherapies market - Revenue and Forecast to 2027 (US$ Million)
7. North America Allergy Immunotherapies Market Analysis– by Treatment
7.1 Overview
7.2 North America Allergy Immunotherapies Market Share, By Treatment, 2019 & 2027 (%)
7.3 Subcutaneous Immunotherapy (SCIT)
7.3.1 Overview
7.3.2 North America Subcutaneous Immunotherapy (SCIT) Market Revenue and Forecasts to 2027 (US$ Million)
7.4 Sublingual Immunotherapy (SLIT)
7.4.1 Overview
7.4.2 North America Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)
8. North America Allergy Immunotherapies Market Analysis– by Allergy Type
8.1 Overview
8.2 North America Allergy Immunotherapies Market Share, By Allergy Type, 2019 & 2027 (%)
8.3 Allergic Rhinitis
8.3.1 Overview
8.3.2 Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)
8.4 Asthma
8.4.1 Overview
8.4.2 Asthma Market Revenue and Forecasts to 2027 (US$ Million)
8.5 Food Allergy
8.5.1 Overview
8.5.2 Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)
8.6 Venom Allergy
8.6.1 Overview
8.6.2 Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)
8.7 Other Allergies
8.7.1 Overview
8.7.2 Others Market Revenue and Forecasts to 2027 (US$ Million)
9. North America Allergy Immunotherapies Market Analysis– by Distribution Channel
9.1 Overview
9.2 North America Allergy Immunotherapies Market Share, By Distribution Channel, 2019 & 2027 (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 North America Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
9.4 Retail Pharmacy
9.4.1 Overview
9.4.2 North America Retail PharmacyMarket Revenue and Forecasts to 2027 (US$ Million)
9.5 Online Pharmacy
9.5.1 Overview
9.5.2 North America Online PharmacyMarket Revenue and Forecasts to 2027 (US$ Million)
10. Allergy Immunotherapies – Geographic Analysis
10.1.1 Overview
10.1.2 orth America: Allergy immunotherapies market - Revenue and Forecast to 2027 (US$ Million)
10.1.3 North America: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.4 North America Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.5 North America Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Allergy immunotherapies market, by Country, 2019 & 2027 (%)
10.1.7 US: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 US Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Canada Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 Mexico Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on North America Allergy Immunotherapies Market
12. Company Profiles
12.1 ALK-Abelló A/S
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 AIMMUNE THERAPEUTICS, INC.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Johnson and Johnson Services, Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
13. Appendix
13.1 Glossary of Terms
LIST OF TABLES
Table 1. North America Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 2. North America Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 3. North America Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 4. US Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 5. US Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 6. US Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 7. Canada Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 8. Canada Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 10. Mexico Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 11. Mexico Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 12. Mexico Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. Glossary of Terms, Allergy Immunotherapies Market
LIST OF FIGURES
Figure 1. North America Allergy Immunotherapies Market Segmentation
Figure 2. North America Allergy Immunotherapies Market Overview
Figure 3. Subcutaneous Immunotherapy (SCIT) Segment Held Largest Share of Allergy immunotherapies market
Figure 4. United States Is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America Allergy Immunotherapies Market- Leading Country Markets (US$ Million)
Figure 6. North America PEST Analysis
Figure 7. Allergy immunotherapies Market Impact Analysis of Driver and Restraints
Figure 8. North America Allergy immunotherapies market Revenue and Forecast to 2027 (USD Million)
Figure 9. North America Allergy Immunotherapies Market Share, by Treatment, 2019 & 2027 (%)
Figure 10. North America Subcutaneous Immunotherapy (SCIT) Market Revenue and Forecasts to 2027 (US$ Million)
Figure 11. North America Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)
Figure 12. North America Allergy Immunotherapies Market Share, by Allergy Type, 2019 & 2027 (%)
Figure 13. Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)
Figure 14. Asthma Market Revenue and Forecasts to 2027 (US$ Million)
Figure 15. Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 16. Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 17. Others Market Revenue and Forecasts to 2027 (US$ Million)
Figure 18. North America Allergy Immunotherapies Market Share, by Distribution Channel, 2019 & 2027 (%)
Figure 19. North America Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 20. North America Retail PharmacyMarket Revenue and Forecasts to 2027 (US$ Million)
Figure 21. North America Online Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 22. North America: Allergy Immunotherapies Market, by Key Country – Revenue (2019) (USD Million)
Figure 23. North America Allergy immunotherapies market Revenue and Forecast to 2027 (USD Million)
Figure 24. North America: Allergy immunotherapies market, by Country, 2019 & 2027 (%)
Figure 25. US: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
Figure 26. Canada: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 27. Mexico: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
Figure 28. Impact of COVID-19 Pandemic on allergy immunotherapies market in North American Countries
- Johnson and Johnson Services, Inc.
- ALK Abello A/S
- Aimmune Therapeutics
- Anergis
- Circassia
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to North America Allergy Immunotherapies Market
Sep 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Sep 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Sep 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Sep 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Sep 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)